Background Influenza is a common illness for its high rates of morbidity and transmission.
The implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 …

Background Scant evidence exists on the real-world effectiveness of quadrivalent live
attenuated influenza vaccines (LAIV-4) in younger children. We aimed to assess the real …

Mucosal immunization is a powerful weapon against viral infection. In this paper, large pore
mesoporous silica nanoparticles (LMSN) with different particle sizes were synthesized for …

The antigenic evolution of the influenza A virus hemagglutinin (HA) gene poses a major
challenge for the development of vaccines capable of eliciting long-term protection. Prior …

Host factors play important roles in influenza A virus (IAV) replication. In order to identify
novel host factors involved in IAV replication, we compared the differentially expressed …

The trajectory of COVID-19 epidemic waves in the general population of Belgium was
analysed by defining quantitative criteria for epidemic waves from March 2020 to early 2023 …

Both pandemic and seasonal influenza are major health concerns, causing significant
mortality and morbidity. Current influenza drugs primarily target viral neuraminidase and …

It is clear that new approaches are needed to promote broadly protective immunity to viral
pathogens, particularly those that are prone to mutation and escape from antibody-mediated …

Influenza A is a highly contagious respiratory illness that spreads globally and results in
millions of cases worldwide. The transmission rate and mortality rate of influenza in the …

Understanding how the global dispersal patterns of seasonal influenza viruses were
perturbed during and after the COVID-19 pandemic is needed to inform influenza …